Cargando…
Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2
SHetA2 is a small molecule drug with promising cancer prevention and therapeutic activity and a high preclinical safety profile. The study objectives were to perform interspecies scaling and pharmacokinetic (PK) modeling of SHetA2 for human PK prediction. The PK data obtained from mice, rats, and do...
Autores principales: | Sharma, Ankur, Benbrook, Doris Mangiaracina, Woo, Sukyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892888/ https://www.ncbi.nlm.nih.gov/pubmed/29634717 http://dx.doi.org/10.1371/journal.pone.0194046 |
Ejemplares similares
-
Bioanalytical method development and validation of HPLCUV assay for
the quantification of SHetA2 in mouse and human plasma: Application to
pharmacokinetics study
por: Sharma, Ankur, et al.
Publicado: (2017) -
SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention
por: Benbrook, Doris Mangiaracina
Publicado: (2022) -
Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
por: Chandra, Vishal, et al.
Publicado: (2021) -
Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2
por: Rai, Rajani, et al.
Publicado: (2022) -
SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugated magnetic microspheres
por: Benbrook, Doris Mangiaracina, et al.
Publicado: (2013)